Pharmacy

Your Article Summary

See Latest Articles

Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting
Current Medical Research and Opinion, 06/25/09

Ritzwoller DF et al. - The presence of pDPN in patients with diabetes was associated with significantly greater comorbidity, greater healthcare service utilization, and higher costs. While this study is limited to the direct medical care costs borne by the health plan, given the association of comorbidities and cost for patients with pDPN, further investigation is needed to determine if management approaches that are effective across chronic illnesses may prove to be beneficial for high cost diabetes patients.

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Tadalafil for the treatment of pulmonary arterial hypertension
Expert Opinion in Pharmacotherapy, 12/14/09

Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(R)) injections versus local anesthetic in osteoarthritis of the hip
Arthritis Research & Therapy, 12/14/09

New central targets for the treatment of obesity
British Journal of Clinical Pharmacology, 12/11/09

 See all of Other Drugs

Today in Pharmacoeconomics...keeping you current

Receive free subspecialty "5-minute updates" via email

Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09

Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09

Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09

 See all of Pharmacoeconomics